Chronic Heart Failure

I. Quality of Life II. Nitrate Therapy

  • Herbert Viefhues
  • Wolfgang Schoene
  • R. Rychlik
  • Asher Kimchi
  • Basil S. Lewis
  • Marija Weiss
Conference proceedings

Table of contents

  1. Front Matter
    Pages I-XI
  2. Introduction

    1. A. Schneeweiss
      Pages 1-1
  3. Quality of Life

    1. Front Matter
      Pages 3-3
    2. H. Viefhues
      Pages 27-32
    3. R. Rychlik
      Pages 33-40
    4. H. Viefhues
      Pages 66-91
    5. M. Bullinger, E. Pöppel
      Pages 92-103
    6. W. Pohl, J.-M. Graf v. d. Schulenburg
      Pages 149-164
    7. H. Troidl
      Pages 172-185
  4. Nitrate Therapy

About these proceedings


A. Schneeweiss Although the syndrome of congestive heart failure has been recognized many years ago, the approach for its evaluation and treatment has until recently, been partial and 'fragmentary'. Various aspects of the disease have been treated according to the evaluation tools and therapeutic measures available at each period. This approach resulted in some of the greatest achievements in the management of heart failure but also left many aspects neglected and also resulted in several paradoxes. Examples of the achievements and limitations of the 'fragmentary' ap­ proach are the use of diuretics and hemodynamic measurements. The devel­ opment of diuretics has provided us with an important tool for helping pa­ tients whose predominant problem was edema. The success of diuretics masked the fact that their use may often be hemodynamically unsound and that they may reduce cardiac output. Only many years after their introduction has the use of diuretics found its appropriate place. Hemodynamic monitoring has gone via the same path. The great contribu­ tion of continuous bedside hemodynamic measurements to understanding heart failure resulted in over-usage by many clinicians, who found themselves treating hemodynamic charts rather than patients. It took almost a decade to realize that hemodynamic improvement, even in the chronic setting, does not necessarily mean symptomatic improvement or an increase in exercise capac­ ity.


Akute Myokardischämie Bypass Herzinsuffizienz Hämodynamik acute myocardial ischaemia artery coronary artery disease coronary heart disease drugs haemodynamics heart heart failure metabolism myocardial infarction research

Editors and affiliations

  • Herbert Viefhues
    • 1
  • Wolfgang Schoene
    • 2
  • R. Rychlik
    • 3
  • Asher Kimchi
    • 4
  • Basil S. Lewis
    • 5
  • Marija Weiss
    • 6
  1. 1.Bochum (W)Federal Republic of Germany
  2. 2.Institut für Medizinische SoziologieWestfälische Wilhelms-UniversitätMünster (W)Federal Republic of Germany
  3. 3.Medizinische ForschungSchwarz Pharma AGMonheim (W)Federal Republic of Germany
  4. 4.Cedars-Sinai Medical CenterUniversity of CaliforniaLos AngelesUSA
  5. 5.Cardiology DepartmentLady Davis Carmel HospitalHaifaIsrael
  6. 6.International Medical AffairsSchwarz Pharma AGMonheim (W)Federal Republic of Germany

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 1991
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-76435-6
  • Online ISBN 978-3-642-76433-2
  • Buy this book on publisher's site